However, approximately 10% to 15% of cancers achieve immortalization via a telomerase-independent mechanism of telomere lengthening, the alternative lengthening of telomeres (ALT) [3], which was first observed in a telomerase-null mutant yeast, even-short telomeres 1 (EST1) [4]. The gene discussed is GPT; the disease is cancer.